GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Ed Mahon reported this story while participating in the USC Annenberg Center for Health Journalism’s 2024 Data Fellowship and received engagement mentoring and funding. Spotlight PA is ...

A good night’s sleep often sets the stage for a positive day. But for the nearly quarter of American adults struggling with ...

Every year, tens of thousands of Americans die from opioid use. Ther were 82,000 opioid-involved overdose deaths in 2022, according to the US Centers for Disease Control and Prevention. The US gets 30 ...

The approval marks the first new class of pain medicine in more than two decades and offers a potential non-addictive alternative to opioids. "Today's approval is a historic milestone for the 80 ...

The approval marks the first new class of pain medicine in more than two decades and offers a potential non-addictive alternative to opioids. "Today's approval is a historic milestone for the 80 ...

A masked psychopath who only strikes on Valentine’s Day mistakes a cynical ad exec and her hopelessly romantic colleague as a killable couple in this highly entertaining genre mashup. Though ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids ... able to use ibuprofen if ...

led to a six percent decrease in daily opioid use. Between 2014 and 2019, opioid overdose deaths in Wisconsin rose by 46% according to data from the Wisconsin Department of Health Services.

Older adults' visual functions— eye movement reaction time, speed, and accuracy—are acutely impaired by alcohol, and those ...

Washington — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.